Suppr超能文献

接受移植的糖尿病肾病患者的死亡风险因素。

Risk factors for mortality in diabetic nephropathy patients accepted for transplantation.

作者信息

Witczak Bartlomiej J, Jenssen Trond, Endresen Knut, Røislien Jo, Hartmann Anders

机构信息

Department of Medicine, Section of Nephrology, Rikshospitalet, University of Oslo, Oslo, Norway.

出版信息

Transplantation. 2007 Aug 15;84(3):356-61. doi: 10.1097/01.tp.0000276935.31584.4c.

Abstract

BACKGROUND

There is a high incidence of silent coronary artery disease (CAD) in patients with diabetes. We wanted to investigate risk factors for mortality, and especially CAD, in a well-defined cohort of diabetic nephropathy transplant candidates accepted for transplantation.

METHODS

From 1999 through 2004, 155 patients underwent work up for living or deceased kidney (KA) or simultaneous pancreas-kidney (SPK) transplantation. The work up included coronary angiography for all patients and 136 were accepted. Mean (SD) age was 50 (12) years, 62% had type 1 diabetes, 73% were males, and 34% were on dialysis. Mean follow-up from time of acceptance for transplantation was 3.6 (1.9) years.

RESULTS

Survival of KA transplanted patients was 97% at 1 year, 89% at 3 years, and 76% at 5 years, whereas in SPK patients 100%, 94%, and 90%, respectively (P=0.065). One- and 3- year survival was only 57% and 20% in those remaining wait-listed (P<0.001). In univariate analysis mortality was associated with KA transplantation (hazard ratio [HR]=0.30, P=0.011) and SPK transplantation (HR=0.10, P=0.001), and age (HR=1.04, P=0.014). In multivariable analysis, KA transplantation (HR=0.28, P=0.006), SPK transplantation (HR=0.09, P=0.001), age (HR=1.06, P=0.002), type 2 diabetes (HR=0.14, P=0.003), and duration of diabetes (HR=0.94, P=0.019) were parameters associated with mortality.

CONCLUSIONS

The only modifiable risk factor was transplantation with risk reduction up to 90%. CAD was not a risk factor for mortality when medically treated and revascularized according to standard guidelines.

摘要

背景

糖尿病患者中无症状冠状动脉疾病(CAD)的发病率很高。我们想在一组明确的等待移植的糖尿病肾病患者队列中,研究死亡率的危险因素,尤其是CAD的危险因素。

方法

1999年至2004年,155例患者接受了活体或尸体肾(KA)移植或胰肾联合移植(SPK)的术前检查。检查包括对所有患者进行冠状动脉造影,其中136例被接受移植。平均(标准差)年龄为50(12)岁,62%为1型糖尿病患者,73%为男性,34%正在接受透析。从接受移植时起的平均随访时间为3.6(1.9)年。

结果

KA移植患者1年生存率为97%,3年生存率为89%,5年生存率为76%;而SPK移植患者的生存率分别为100%、94%和90%(P = 0.065)。仍在等待名单上的患者1年和3年生存率仅为57%和20%(P < 0.001)。单因素分析显示,死亡率与KA移植(风险比[HR]=0.30,P = 0.011)、SPK移植(HR = 0.10,P = 0.001)以及年龄(HR = 1.04,P = 0.014)相关。多变量分析显示,KA移植(HR = 0.28,P = 0.006)、SPK移植(HR = 0.09,P = 0.001)、年龄(HR = 1.06,P = 0.002)、2型糖尿病(HR = 0.14,P = 0.003)以及糖尿病病程(HR = 0.94,P = 0.019)是与死亡率相关的参数。

结论

唯一可改变的危险因素是移植,风险降低可达90%。按照标准指南进行药物治疗和血运重建时,CAD不是死亡的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验